Background: Although the peri-operative mortality following pancreaticoduodenectomy (PD) for distal
Introduction
The only potentially curative treatment of distal cholangiocarcinomas (DCC) is an oncologic pancreaticoduodenectomy (PD), yielding a 5-year overall survival (OS) rate less than 30% and a median OS of 37 months.
1 This prognosis is closely related to local recurrence and metastatic spread, which require an appropriate treatment.
2 Therefore increased understanding of the risk factors of recurrence is fundamental to improve long term outcomes. The post-operative mortality following PD is decreasing, due to improvements in peri-operative care, surgical techniques and centralization to high-volume institutions.
3,4 However despite these improvements, the post-operative morbidity remains high, from 30% to 50%. 5 This morbidity is particularly linked to delayed gastric emptying (DGE), pancreatic and biliary fistulae, intra-abdominal infection and hemorrhage. 6 Control of these complications depends on optimal preparation of the patient, meticulous and standardized operative technique, careful postoperative monitoring, early and appropriate management of complications. 7 Recent evidence has shown that enhanced recovery after surgery protocols decrease hospital stay following PD, particularly in elderly patients. 8, 9 To date, few studies with a small number of patients have focused on post-operative morbidity after PD for patients with DCC. The aim of this multicenter study was to examine the effect of factors that may affect long term outcomes following PD in patients presenting with DCC.
Methods
All consecutive patients who underwent PD for DCC in 5 tertiary referral centers between January 2000 and December 2015 were extracted from prospective maintained databases and were analyzed retrospectively. Only patients with pathologically confirmed DCC were included. Pancreatic, ampullary and duodenal carcinomas were excluded from the analysis. This work was conducted after approval by the institutional review boards.
The data collected included demographics (age, sex, body mass index (BMI), American Society of Anesthesiologists (ASA) score, 10 tumor type, lymph node status, duration of surgery, venous or arterial resection and reconstruction, concomitant abdominal surgery, and peri-operative allogenic blood transfusion (PBT)), defined by the necessary of transfusion during the surgery or the hospitalization period. Post-operative pancreatic fistula was classified according to the International Study Group of Pancreatic Fistula (ISGPF) classification and only grades B and C were considered as recently recommended. 11,12 Delayed gastric emptying (DGE) were classified according to the International Study Group of Pancreatic Surgery classification (ISGPS). 13 In this study, only DGE of grades B and C were considered. Postpancreatectomy hemorrhage, including intra-and extraluminal hemorrhage were classified as per the ISGPS. 14 Biliary fistula, was defined as the presence of bile in the drain fluid. Systemic infections were defined as the presence of infectious signs requiring the administration of systemic antibiotics. Post-operative complications were classified according the Clavien-Dindo classification system. 15 Major complications were defined by a complication IIIB in Clavien-Dindo classification. Perioperative mortality was defined as death during the initial hospital stay. Mortality during the 30 and 90 postoperative days was also documented.
Surgery
All PD were performed following the standard Whipple procedure and Child reconstruction (using pancreaticojejunostomy), by senior pancreatic surgeons. All patients had intraoperative frozen section examination of the proximal main bile duct and the pancreatic section of the specimen. If invaded, additional resection to achieve a negative margin was performed. During reconstruction, pancreatic duct intubation was left to the discretion of the operator, but was generally performed in patients with small duct size (<3 mm) or soft pancreatic texture.
Pathology
The histological diagnosis was established by an expert pathologist in biliopancreatic disease according to the macroscopic and microscopic aspect and immunohistochemistry (with cytokeratin 7 and 20) in all patients. When distinction between DCC and others peri-pancreatic malignancies was questionable, specimen was reviewed by a second pathologist and patients were only included if there was agreement. Considering the microscopic margin involvement, pathologists used a definition based on a 1 mm clearance, to specify R0 resection.
Follow-up protocol
After resection, adjuvant chemotherapy was discussed in a multidisciplinary collaborative meeting. All patients were followed every 3 months. A computed tomography scan was systematically performed every 3 months during the first 2 years after surgery and every 6 months thereafter. Follow-up data were obtained through routine clinical visits or through personal contact. Patients who died during the first 90 post-operative days were excluded from the survival analysis. The end of follow-up was between September 2017 and October 2017 or at the time of death.
Recurrence
Recurrence was considered when new lesion was shown on imaging finding without histological confirmation. When recurrence was diagnosed, the treatment strategy was determined at a multidisciplinary collaborative meeting, which was attended by pancreatic surgeons, radiologists, oncologists and gastroenterologists. According to their general condition and the degree of disease extension, the patients were treated with chemotherapy, using gemcitabin or gemcitabin plus oxaliplatin (GEMOX), radiation therapy or hepatic radiofrequency ablation. For localized non-progressive liver metastases, the feasibility of radiofrequency ablation and surgical resection were systematically discussed.
Statistical analysis
Quantitative variables are expressed as medians and inter quartile range (IQR) and qualitative variables are expressed as numbers and percentages. Survival analysis was performed by KaplanMeier curve analysis and the results were compared with the logrank test. All variables with P < 0.10 by univariate analysis were entered into a multivariate model (i.e., COX proportional hazard model). The best final multivariate model was selected using a stepwise method in order to only retain variables with a P value of <0.05. To appreciate the accuracy of the final Cox model (both for OS and DFS), the Harrell's C-index were calculated. The absence of collinearity effect between variables was appreciated by calculation of the variance inflation factor in each best final selected model. All statistical analyses were performed using R statistical software, version 2.15.1 (http://www.r-project.org/).
Results
During the study period, 201 (93%) patients on 217 patients who underwent PD with curative intent for DCC were included for
